RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan)

Cancer

Volumn 104, Issue 5, 2005, Pages 943-951

  Nakazawa, Tadao ^a   Kondo, Tetsuo ^a   Kobayashi, Yoshihiko ^a,b   Takamura, Noboru ^c   Murata, Shin Ichi ^a   Kameyama, Kaori ^d   Muramatsu, Akira ^e   Ito, Kohichi ^f   Kobayashi, Makio ^g   Katoh, Ryohei ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Fuji Biomedix Co Ltd   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d KEIO UNIVERSITY HOSPITAL   (Japan)

^e Kofu Municipal Hospital   (Japan)

^f ITO HOSPITAL   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Japanese; Papillary thyroid carcinoma; Patient age; RET rearrangement; Reverse transcriptase polymerase chain reaction

Indexed keywords

COMPLEMENTARY DNA; IODINE; PROTEIN RET; RNA;

ADULT; ARTICLE; DIETARY INTAKE; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; GENE REARRANGEMENT; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 23844491862     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21270     Document Type: Article

References (39)

1. Ezaki H, Ebihara S, Fujimoto Y, et al. Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special preference to predominance of papillary type. Cancer. 1992;70:808-814.
2. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell. 1985;42:581-588.
3. Santoro M, Carlomagno F, Hay ID, et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest. 1992;89:1517-1522.
4. Bongarzone I, Butti MG, Coronelli S, et al. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res. 1994;54: 2979-2985.
5. Lam AK, Montone KT, Nolan KA, et al. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters. Hum Pathol. 1998; 29:565-568.
6. Tallini G, Santoro M, Helie M, et al. RET/PTC oncogene activation defines a subset of papillary carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res. 1998;4:287-294.
7. Jhiang SM, Caruso DR, Gilmore E, et al. Detection of the PTC/refTPC oncogene in human thyroid cancers. Oncogene. 1992;7:1331-1337.
8. Nikiforova MN, Caudill CM, Biddinger P. Nikiforov YE. Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol. 2002;10:15-22.
9. Sugg SE, Ezzat S, Zheng E, et al. Oncogene profile of papillary thyroid carcinoma. Surgery. 1999;125:46-52.
10. Zou MJ, Shi YF, Farid NR. Low rate of ret proto-oncogene activation (PTC/refTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer. 1994;73:176-180.
11. Chua EE, Wu WM, Tran KT, et al. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia. J Clin Endocrinol Metab. 2000; 85:2733-2739.
12. Lee CH, Hsu LS, Chi CW, et al. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas. J Clin Endocrinol Metab. 1998;83: 1629-1632.
13. Namba H, Yamashita S, Pei HC, et al. Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors. Endocrinol Jpn. 1991;38:627-632.
14. Wajjwalku W, Nakamura S, Hasegawa Y, et al. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res. 1992;83:671-675.
15. Ishizuka Y, Kobayashi S, Ushijima T, et al. Detection of refTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene. 1991;6:1667-1672.
16. Kitamura Y, Minobe K, Nakata T, et al. Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan. J Hum Genet. 1999;44:96-102.
17. Motomura T, Nikiforov YE, Namba H, et al. ret rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid. 1998;8:485-489.
18. Nikiforov YE, Rowland JM, Bove KE, et al. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 1997;57:1690-1694.
19. Rabes HM, Demidchik EP, Sidorow JD, et al. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res. 2000; 6:1093-1103.
20. Fugazzola L, Pilotti S, Pinchera A, et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res. 1995;55:5617-5620.
21. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene. 1995;11:2459-2467.
22. Smida J, Salassidis K, Hieber L, et al. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int J Cancer. 1999;80:32-38.
23. Thomas GA, Bunnell H, Cook HA, et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab. 1999;84:4232-4238.
24. Bounacer A, Wicker R, Caillou B, et al. High prevalence of activating ret proto-oncogene rearrangements, thyroid tumors from patients who had received external radiation. Oncogene. 1997;15:1263-1273.
25. Nikiforov YE. RET/PTC rearrangement in thyroid tumors. Endocr Pathol. 2002;13:3-16.
26. Grieco M, Santoro M, Berlingieri MT, et al. PTC is a novel rearrangement form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 1990;60:557-563.
27. Santoro M, Dathan NA, Berlingieri MT, et al. Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene. 1994;9:509-516.
28. Hedinger C, Williams HD, Sobin LH. Histological classification of thyroid tumours. In: Hedinger C, Williams ED, Sobin LH, editors. Histological typing of thyroid tumours. World Health Organization international histological classification of tumours. 2nd edition. Paris: Springer-Verlag, 1988:3-18.
29. Kobayashi Y, Kawaoi A, Katoh R. Mutation of ras oncogene in di-isopropanolnitrosamine-induced rat thyroid carcinogenesis. Virchows Arch. 2002;441:289-295.
30. Ishizuka Y, Ushijima T, Sugimura T, Nagao M. cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochem Biophys Res Commun. 1990;168:402-408.
31. Fenton CL, Lukes Y, Nicholson D, et al. The ret/PTC mutations are common in sporadic papillary carcinoma of children and young adults. J Clin Endocrinol Metab. 2000;85: 1170-1175.
32. Shi YF, Zou MJ, Schmidt LI, et al. High rates of rascodon 61 mutation in thyroid tumors in an iodine-deficient area. Cancer Res. 1991;51:2690-2693.
33. Bongarzone I, Fugazzola L, Vigneri P, et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab. 1996;81:2006-2009.
34. Bongarzone I, Vigneri P, Mariani L, et al. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin Cancer Res. 1998;4:223-228.
35. Sugg SL, Ezzat S, Rosen IB, et al. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab. 1998;83:4116-4122.
36. Eng C, Mulligan LM, Healey CS, et al. Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res. 1996;56: 2167-2170.
37. Williams GH, Rooney S, Thomas GA, Cummins G, Williams ED. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer. 1996;74:585-589.
38. Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-1991. Cancer. 1997;79:564-573.
39. Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164:658-661.